| Literature DB >> 33422421 |
Rebika Dhiman1, Vaishali Rakheja2, Rohit Saxena3.
Abstract
In recent past, major pandemics and epidemics have occurred due to the emergence and resurgence of the novel strains of viruses like Influenza [HINI-A "Spanish Flu", H1N1-Novel A "Swine flu"], Corona [Middle East Respiratory Syndrome (MERS), Severe acute respiratory syndrome (SARS-CoV-1, SARS-CoV-2)] and Ebola virus [Ebola virus disease]. These infectious diseases may have several ocular manifestations and rarely might be the presenting symptom of the underlying disease. The eyes can act as a portal of entry and/or route of viral transmission for these pathogens. Therefore, an ophthalmologist/optometrist needs to act with ample preparedness and responsibility. Establishing a standard of care in ophthalmic practice by modifying the conventional examination techniques and adopting tele-ophthalmology model to triage the patients can control the community spread of the disease. This article aims to elucidate the ocular manifestations in these pandemics and measures that should be adopted in ophthalmic practice to prevent the disease transmission.Entities:
Keywords: Epidemic; Eye; Pandemic; Prevention; Viral pandemic
Mesh:
Year: 2021 PMID: 33422421 PMCID: PMC8045749 DOI: 10.1016/j.optom.2020.10.005
Source DB: PubMed Journal: J Optom ISSN: 1989-1342
Figure 1The timeline of various contagious viral outbreaks in the world.
Figure 2The magnitude of public health problem caused by the major viral pandemics in the past and the status of the present pandemic up to the date of final submission (This figure is for illustrative purpose only and does not depict the actual statistical representation of the data).
Summary of systemic and ocular manifestations of recent pandemics.
| Disease | Systemic manifestations | Ocular manifestations | The eye as a potential route for transmission |
|---|---|---|---|
| H1N1-A Spanish Flu | Flu-like symptoms- fever, malaise, cough, sore throat. | Intense orbital pain, ocular motility limitation, accommodation deficits, sub-conjunctival, and intra-ocular hemorrhage. | Ocular transmission is not known. However, ocular protection prevents access to the respiratory tract via the ocular mucosal surface. |
| H1N1-Novel A Swine Flu | Severe cases- ARDS, multisystem failure, death. | B/L acute Conjunctivitis (65%), retinopathy (4.5%), optic Neuritis(3.4%), uveal Effusion syndrome(8%). Other less common manifestations being disc hemorrhage, sub-macular hemorrhage, acute retinitis. | |
| Ebola virus | Fever, sore throat, abdominal pain, diarrhea, arthralgia, conjunctival congestion. | B/L sub-conjunctival hemorrhages(60%), hemorrhagic conjunctivitis, uveitis(20-26%), cataract (10%), optic neuropathy (3%),vitritis, scleritis (35%). | The persistence of the Ebola virus in aqueous humor has been identified in one patient, who had acute hypertensive anterior uveitis that progressed to panuveitis. |
| Severe cases- bleeding diathesis, shock, death. | Although ocular transmission is unknown, use of personal protective equipment (PPE) to protect the mucosal surfaces including ocular mucosal surface from exposure is recommended | ||
| SARS-CoV-1 | Seasonal flu-like symptoms- fever, cough, chills, rigor. | No case with ocular manifestations was reported. | There is possibility of unprotected eyes being the possible route of entry or viral transmission. But there is poor yield of virus from conjunctval swabs using RT-PCR. |
| MERS-CoV | Severe cases- B/L atypical pneumonia, multisystem dysfunction, death. | A rare occurrence- conjunctivitis (2%). | Conjunctiva can be possible route of transmission |
| SARS-CoV-2 | Conjunctival involvement (1.6-32%) -follicular, hemorrhagic and pseudomembranous conjunctivitis, conjunctival hyperemia, xerophthalmia (4.5%), epiphora, keratitis (2.6%), hyper-reflective lesions at the level of inner plexiform layer and ganglion cell layer. | There is evidence of ocular transmission. But a low yield from conjunctival and tear secretions by RT-PCR may reflect a low sensitivity of this test or heightened immune response due to delay in sampling. |
Figure 3Modification of the slit lamp biomicrosopy technique by placing used x-ray film to separate the viewing arm from the patient’s end.